Public Comments for: SB278 - Federal 340-B Drug Pricing Program; impacts within the Commonwealth.
Last Name: Spencer Organization: Artifex Advisors on behalf of the Pharmaceutical Industry Labor Management Association Locality: Caret

Honorable Delegate: Please OPPOSE SB278 — Drug manufacturers; permitting and registration, certain conditions related to 340B-covered drugs. This federal program needs to be reformed on a federal level. The best way to lower drug prices is to increase supply; we support Virginia’s plan to bolster the pharmaceutical industry here; and we, the Building Trades, are ready to go to work. Please OPPOSE SB 278; thank you! Respectfully Submitted, Lou Spencer Artifex Advisors, LLC. On behalf of the Pharmaceutical Industry Labor Management Association (PILMA) Virginia Commonwealth Director A partnership between the Building Trades and the Pharmaceutical Companies

End of Comments